| . | Time to normal haemostasis function . |
|---|---|
Antiplatelet drugs | |
NSAIDs | 24 hours |
Aspirin | 3–4 days |
Clopidogrel | 5–7 days |
Prasugrel | 5–7 days |
Ticagrelor | 3–5 days |
Cangrelor | 60–90 minutes |
Tirofiban | 4–8 hours |
Eptifibatide | 4–8 hours |
Abciximab | 2–48 hours |
Fibrinolytic drugs | |
Alteplase, reteplase, streptokinase, urokinase | 24–48 hours |
| . | Time to normal haemostasis function . |
|---|---|
Antiplatelet drugs | |
NSAIDs | 24 hours |
Aspirin | 3–4 days |
Clopidogrel | 5–7 days |
Prasugrel | 5–7 days |
Ticagrelor | 3–5 days |
Cangrelor | 60–90 minutes |
Tirofiban | 4–8 hours |
Eptifibatide | 4–8 hours |
Abciximab | 2–48 hours |
Fibrinolytic drugs | |
Alteplase, reteplase, streptokinase, urokinase | 24–48 hours |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
